Circulating Tumor DNA in Head and Neck Cancer: A Review From the American Head and Neck Society.
Society-level guidance now clarifies when blood-based cancer tests help manage head and neck cancers, including HPV-related forms.
AHNS authoritative review summarizes evidence for ctDNA in head and neck cancer across HPV-positive oropharyngeal cancers, HPV-negative HNSCC, and mucosal melanoma; provides society-level guidance on clinical utility and implementation. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- narrative review (American Head and Neck Society endorsed)
- Category
- early_cancer_detection
- Maturity
- Exploratory
- Journal
- JAMA Otolaryngol Head Neck Surg
Why it surfaced
Society-endorsed review in JAMA Otolaryngology provides a definitive synthesis of ctDNA evidence in an underrepresented tumor type. Relevant to Pulse pipeline for ctDNA adoption tracking and head and neck cancer surveillance protocols.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.